TFS CAPITAL LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 127 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$94,000
-20.3%
20,220
-0.6%
0.02%
+4.5%
Q2 2016$118,000
-78.5%
20,352
-77.6%
0.02%
-72.2%
Q1 2016$550,000
+107.5%
90,971
+93.7%
0.08%
+203.8%
Q3 2015$265,000
-43.5%
46,971
+11.0%
0.03%
-43.5%
Q2 2015$469,000
+191.3%
42,311
+300.6%
0.05%
+206.7%
Q4 2014$161,000
-23.0%
10,561
-45.6%
0.02%
-16.7%
Q3 2014$209,000
-91.5%
19,425
-87.9%
0.02%
-90.7%
Q2 2014$2,457,000
+845.0%
160,922
+759.9%
0.19%
+1508.3%
Q4 2013$260,00018,7140.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders